|
|
||||||||


*
Research Institute, Palo Alto Medical Foundation, Palo Alto, CA 94301;
Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, OH 45267; and
DNAX Research Institute of Molecular and Cellular Biology, Inc., Palo Alto, CA 94304
The costimulatory ligands CD80 and CD86 play a crucial role in the
initiation and maintenance of an immune response. We demonstrate that
whereas infection of human monocytes with viable tachyzoites of
Toxoplasma gondii resulted in rapid induction of expression
of CD80 and up-regulation of expression of CD86, incubation with killed
organisms failed to alter the levels of expression of these
costimulatory ligands. The T. gondii-mediated changes in
levels of expression of these molecules are critical to the T cell
response to the parasite. Proliferation of resting T cells in response
to parasite-infected cells was dependent on both CD80 and CD86. More
importantly, early production of IFN-
in response to T.
gondii by T cells from T. gondii-seronegative
individuals occurred only after stimulation with monocytes that
exhibited increased expression of CD80 and CD86 (monocytes infected
with viable parasites) and was almost completely ablated by the
combination of anti-CD80 plus anti-CD86 mAb. Moreover,
proliferation and IFN-
production by CD4+
CD45RA+ T cells from unexposed individuals were dependent
on both CD80 and CD86. These data indicate that pathogen-monocyte
interaction influences the ensuing T cell response.
This article has been cited by other articles:
![]() |
H. Xu, K. K. Dhanireddy, and A. D. Kirk Human Monocytes as Intermediaries between Allogeneic Endothelial Cells and Allospecific T Cells: A Role for Direct Scavenger Receptor-Mediated Endothelial Membrane Uptake in the Initiation of Alloimmunity J. Immunol., January 15, 2006; 176(2): 750 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nierkens, M. Aalbers, M. Bol, R. Bleumink, P. van Kooten, L. Boon, and R. Pieters Differential Requirement for CD28/CTLA-4-CD80/CD86 Interactions in Drug-Induced Type 1 and Type 2 Immune Responses to Trinitrophenyl-Ovalbumin J. Immunol., September 15, 2005; 175(6): 3707 - 3714. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Andrade, M. Wessendarp, and C. S. Subauste CD154 Activates Macrophage Antimicrobial Activity in the Absence of IFN-{gamma} through a TNF-{alpha}-Dependent Mechanism J. Immunol., December 15, 2003; 171(12): 6750 - 6756. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Wille, E. N. Villegas, L. Craig, R. Peach, and C. A. Hunter Contribution of Interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 Ligand Pathways to the Development of a Pathological T-Cell Response in IL-10-Deficient Mice Infect. Immun., December 1, 2002; 70(12): 6940 - 6947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Johnson, C. W. Roberts, C. Pope, F. Roberts, M. J. Kirisits, R. Estes, E. Mui, T. Krieger, C. R. Brown, J. Forman, et al. In Vitro Correlates of Ld-Restricted Resistance to Toxoplasmic Encephalitis and Their Critical Dependence on Parasite Strain J. Immunol., July 15, 2002; 169(2): 966 - 973. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Brodskyn, G. K. DeKrey, and R. G. Titus Influence of Costimulatory Molecules on Immune Response to Leishmania major by Human Cells In Vitro Infect. Immun., February 1, 2001; 69(2): 665 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Subauste and M. Wessendarp Human Dendritic Cells Discriminate Between Viable and Killed Toxoplasma gondii Tachyzoites: Dendritic Cell Activation After Infection with Viable Parasites Results in CD28 and CD40 Ligand Signaling That Controls IL-12-Dependent and -Independent T Cell Production of IFN-{gamma} J. Immunol., August 1, 2000; 165(3): 1498 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Villegas, U. Wille, L. Craig, P. S. Linsley, D. M. Rennick, R. Peach, and C. A. Hunter Blockade of Costimulation Prevents Infection-Induced Immunopathology in Interleukin-10-Deficient Mice Infect. Immun., May 1, 2000; 68(5): 2837 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hiroishi, T. Tuting, and M. T. Lotze IFN-{alpha}-Expressing Tumor Cells Enhance Generation and Promote Survival of Tumor-Specific CTLs J. Immunol., January 15, 2000; 164(2): 567 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Villegas, M. M. Elloso, G. Reichmann, R. Peach, and C. A. Hunter Role of CD28 in the Generation of Effector and Memory Responses Required for Resistance to Toxoplasma gondii J. Immunol., September 15, 1999; 163(6): 3344 - 3353. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Subauste, M. Wessendarp, R. U. Sorensen, and L. E. Leiva CD40-CD40 Ligand Interaction Is Central to Cell-Mediated Immunity Against Toxoplasma gondii: Patients with Hyper IgM Syndrome Have a Defective Type 1 Immune Response That Can Be Restored by Soluble CD40 Ligand Trimer J. Immunol., June 1, 1999; 162(11): 6690 - 6700. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. Fischer, R. Dorfler, B. Schade, and U. Hadding Differential CD86/B7-2 expression and cytokine secretion induced by Toxoplasma gondii in macrophages from resistant or susceptible BALB H-2 congenic mice Int. Immunol., March 1, 1999; 11(3): 341 - 349. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |